Post-valvular energy exchange in bicuspid aortic valve with regurgitation and stenosis and its association with left ventricular workload: a 4D flow magnetic resonance imaging cross-sectional study. [PDF]
Aliabadi S +4 more
europepmc +1 more source
Strategic Reintervention With Marked Oversizing and Overexpansion in TAV-in-SAV for Hemolytic Paravalvular Leak. [PDF]
Saigan M +9 more
europepmc +1 more source
Tricuspid vs Bicuspid Aortic Valve Endocarditis: Delayed Symptom-Onset-to-Diagnosis Time in Bicuspid Patients Increases Their Complication Burden. [PDF]
Huntley GD +10 more
europepmc +1 more source
Predicting procedural outcomes in transcatheter aortic valve implantation: a scoping review of numerical patient-specific simulations. [PDF]
Grossi B +7 more
europepmc +1 more source
Comparative Effects of Different Proteases on the Non-Volatile Taste Compounds and Volatile Flavor Fingerprints of <i>Sarcodon imbricatus</i> Hydrolysates. [PDF]
Guan J +9 more
europepmc +1 more source
A Tetrameric Biotin-Avidin Scaffold Using Anti-CD19 (FMC63) Traptavidin Fusion Enables High-Avidity CAR-T Cells for Leukemia Therapy. [PDF]
Ko HL +10 more
europepmc +1 more source
Related searches:
Optimal strategies to manage embolization of transcatheter aortic valve implantation (TAVI) devices are unclear; valve-in-valve (ViV) is often used. We aimed to describe through one-single center experience its rate, causes, consequences, and management as well as the rate and relevance of commissural alignment (CA) in this context.We identified across
Mario Garcia Gomez +2 more
exaly +3 more sources
Transcatheter aortic valve replacement (TAVR) has become more common than surgical aortic valve replacement since 2016, with over 200,000 procedures globally each year. As patients increasingly outlive their TAVR devices, managing these cases is a growing concern.
Gilbert Tang +2 more
exaly +4 more sources
Redo transcatheter aortic valve replacement in degenerated transcatheter bioprosthesis (TAV-in-TAV)
Expert Review of Cardiovascular Therapy, 2023With the expanding indications of transcatheter aortic valve replacement (TAVR) to younger and low-risk patients, the life expectancy of patients currently undergoing TAVR will likely outlive the durability of transcatheter bioprosthesis. Consequently, the number of failed transcatheter bioprosthesis requiring surgical valve explant or redo TAVR is ...
Juan, Sánchez-Ceña +7 more
openaire +2 more sources

